Clinical Trial Update: Neoadjuvant Immunochemotherapy in PD-L1-negative LACC [Phase 2]

View source ↗

Summary

A Phase 2 trial is evaluating neoadjuvant chemoimmunotherapy for PD-L1-negative locally advanced cervical cancer and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Snippet

Sponsor: Tongji Hospital | Conditions: Cervical Cancer, Locally Advanced Cervical Cancer | Phase 2 | Status: RECRUITING